TT-232: An anti-tumour and anti-inflammatory peptide therapeutic in clinical development

International Journal of Peptide Research and Therapeutics

Volumn 11, Issue 1, 2005, Pages 3-15

  Kéri, György ^a,b,d   Schwab, Richard ^b   Szokolóczi, Orsolya ^a,b   Szüts, Tamás ^c   Szolcsányi, János ^d  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^c Biostatin Research and Development Ltd   (Hungary)

^d UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Analgesic activity; Anti inflammatory activity; Anti tumour activity; Clinical development; Neurogenic inflammation; Somatostatin analogue; TT 232

Indexed keywords

AMINO ACID; ANGIOPEPTIN; ANTINEOPLASTIC AGENT; AZATHIOPRINE; BACLOFEN; CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2 INHIBITOR; DACARBAZINE; DEPREOTIDE TC 99M; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLLYSYLCYSTEINYLTHREONINAMIDE 2,6 DISULFIDE; DICLOFENAC; ETOPOSIDE; GENISTEIN; LAN 7; MELOXICAM; METHOTREXATE; MORPHINE; NONSTEROID ANTIINFLAMMATORY AGENT; OCTREOTIDE; PENTETREOTIDE; PERTUSSIS TOXIN; PROTEIN TYROSINE KINASE INHIBITOR; SOMATOSTATIN; SOMATOSTATIN RECEPTOR 1; SOMATOSTATIN RECEPTOR 4; SUBSTANCE P; UNCLASSIFIED DRUG; UNINDEXED DRUG; VAPREOTIDE;

ANALGESIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; B LYMPHOCYTE ACTIVATION; BRADYCARDIA; BURN; CLINICAL TRIAL; DOSE RESPONSE; DRUG ANTAGONISM; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG INHIBITION; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG STRUCTURE; DRUG SYNTHESIS; ENDOCRINE DISEASE; ESOPHAGUS VARICES BLEEDING; HUMAN; HYPERALGESIA; LUNG METASTASIS; MELANOMA; NONHUMAN; RHEUMATOID ARTHRITIS; T LYMPHOCYTE ACTIVATION; VEIN OCCLUSION;

ANIMALIA;

EID: 27644544592     PISSN: 15733149     EISSN: 15733904     Source Type: Journal    
DOI: 10.1007/s10989-004-1715-1     Document Type: Article

References (41)

1. Brittain, D. E. A., Watterson, M. P., Claridge, T. D. W., Smith, M. D. and Fleet, G. W. J.: 2000, J. Chem. Soc. Perkin Trans. 1(21), 3655-3665.
2. Diaconu, C. C., Szathmari, M., Keri, G. and Venetianer, A.: 1999, Br. J. Cancer. 80(8), 1197-1203.
3. Gamse, R., Leeman, S. E., Holzer, P. and Lembeck, F.: 1981, Naunyn. Schmiedebergs Arch. Pharmacol. 317(2), 140-148.
4. Gibbons, W. A., Hughes, R. A., Szeto, A., Charalambous, M., Aulabaugh, A., Mascagni, P. and Toth, I.: 1990, Liebigs Ann. Chem. 12, 1175-1183.
5. Gruner, S. A., Keri, G., Schwab, R. and Venetianer A. Kessler, H.: 2001, Org. Lett. 3(23), 3723-3725.
6. Gyergyai, F., Gödény, M., Szüts, T., Kéri, Gy., Sármay, G. and Bodrogi, I.: 2003, European Journal of Cancer Supplements. 1, 297-.
7. Helyes, Z., Than, M., Oroszi, G., Pinter, E., Nemeth, J., Keri, G. and Szolcsanyi, J.: 2000, Neurosci. Lett. 278(3), 185-188.
8. Helyes, Z., Pinter, E., Nemeth, J., Keri, G., Than, M., Oroszi, G., Horvath, A. and Szolcsanyi, J.: 2001, Br. J. Pharmacol. 134(7), 1571-1579.
9. Helyes, Z., Pinter, E., Nemeth, J. and Szolcsányi, J.: 2003, Curr. Med. Chem. - Anti-Inflammatory & Anti-Allergy Agent. 2, 191-218.
10. Helyes, Z., Szabo, A., Nemeth, J., Jakab, B., Pinter, E., Banvolgyi, A., Keraskai, L., Keri, G. and Szolcsanyi, J.: 2004, Arthritis Rheum. 50(5), 1677-1685.
11. Jaspers, H., Horvath, A., Mezo, I., Keri, G. and Van Binst, G.: 1994, Int. J. Peptide Protein Res. 43(3), 271-276.
12. Keri, G., Mezo, I., Horvath, A., Vadasz, Z., Balogh, A., Idei, M., Vantus, T., Teplan, I., Mak, M. and Horvath, J.: 1993a, Biochem. Biophys. Res. Commun. 191(2), 681-687.
13. Keri, G., Mezo, I., Vadasz, Z., Horvath, A., Idei, M., Vantus, T., Balogh, A., Bokonyi, G., Bajor, T., Teplan, I., Tamas, J., Mak, M., Horvath, J. and Csuka, O.: 1993b, Pept. Res. 6(5), 281-288.
14. Keri, G., Erchegyi, J., Horvath, A., Mezo, I., Idei, M., Vantus, T., Balogh, A., Vadasz, Z., Bokonyi, G., Seprodi, J., Teplan, I., Csuka, O., Tejeda, M., Gaal, D., Szegedi, Z., Szende, B., Roze, C., Kalthoff, H. and Ullrich, A.: 1996, Proc. Natl. Acad. Sci. 93(22), 12513-12518.
15. Keri, G., Racz, G., Magyar, K., Orfi, L., Schwab, R., Hegymegi, B. B. and Szende, B.: 2004, Ann. N. Y. Acad. Sci. 1010, 109-112.
16. Lee, J. U., Hosotani, R., Wada, M., Doi, R., Koshiba, T., Fujimoto, K., Miyamoto, Y., Tsuji, S., Nakajima, S., Hirohashi, M., Uehara, T., Arano, Y., Fujii, N. and Imamura, M.: 2002, Eur. J. Cancer. 38(11), 1526-1534.
17. Lifferth, A., Birr, C., and Braum, G. 2000. Method for producing biostatin (TT-232 triacetate) and analogues thereof. Patent, Internationale Veröffentlichungsnummer, WO 00/11031.C
18. Lohof, E., Burkhart, F., Born, M.A., Planker, E., and Kessler, H. 1999. in: Abel, A. (ed.), Advances in amino acid mimetics and peptidomimetics, Vol. 2. JAI Press Inc. Stanford, Connecticut, pp. 263-292.
19. Patel, Y. C., Greenwood, M. T., Panetta, R., Demchyshyn, L., Niznik, H. and Srikant, C. B.: 1995, Life Sci. 57(13), 1249-1265.
20. Pinter, E., Helyes, Z., Nemeth, J., Porszasz, R., Petho, G., Than, M., Keri, G., Horvath, A., Jakab, B. and Szolcsanyi, J.: 2002, Naunyn Schmiedebergs Arch. Pharmacol. 366(2), 142-150.
21. Schwab, R. E., Froidevaux, S., Paku, S., Tejeda, M., Szende, B., Pap, A., Beglinger, C, Eberle, A. N. and Keri, G.: 2001, Anticancer Res. 21(1A), 71-75.
22. Siegrist, W., Solca, F., Stutz, S., Giuffrè, L., Carrel, S., Girard, J. and Eberle, A. N.: 1989, Cancer Res. 49(22), 6352-6358.
23. Siegrist, W., Stutz, S. and Eberle, A. N.: 1994, Cancer Res. 54(10), 2604-2610.
24. Siehler, S., Seuwen, K. and Hoyer, D.: 1998, Eur. J. Pharmacol. 348(2-3), 311-320.
25. Simon, A., Czajlik, A., Perczel, A., Keri, G., Nyikos, L., Emri, Z. and Kardos, J.: 2004, Biochem. Biophys. Res. Commun. 316(4), 1059-1064.
26. Stetak, A., Lankenau, A., Vantus, T., Csermely, P., Ullrich, A. and Keri, G.: 2001, Biochem. Biophys. Res. Commun. 285(2), 483-488.
27. Stetak, A., Keri, G. and Ullrich, A.: 2004, 'Pyruvate-Kinase as a Novel Target Molecule'. EP No. 1390525.
28. Suhara, Y., Hildreth, J. E. K. and Ichikawa, Y.: 1996, Tetrahedron Lett. 37(10), 1575-1578.
29. Szende, B. and Keri, G.: 2003, Anti-Cancer Drugs. 14(8), 585-588.
30. Szende, B., Horvath, A., Bokonyi, G. and Keri, G.: 2003, Br. J. Cancer. 88(1), 132-136.
31. Szolcsanyi, J. 2002. Anti-infalmmatory, anti-nociceptive and anti-hyperalgesic effect of TT-232 in rats and mice. Report, Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, University of Pecs, Hungary.
32. Tejeda, M., Gaal, D., Schwab, R. E., Pap, A., Szuts, T. and Keri, G.: 2000, Anticancer Res. 20(2A), 1023-1027.
33. Tejeda, M., Gaal, D., Csuka, O., Ullrich, A., Schwab, R., Pap, A., Horvath, A. and Keri, G.: 2003, Cancer Detect. Prev. 27(2), 155-162.
34. ten Bokum, A. M., Lichtenauer-Kaligis, E. G., Melief, M. J., Koetsveld, P. M.van, Bruns, C., Hagen, P. M.van, Hofland, L. J., Lamberts, S. W. and Hazenberg, M. P.: 1999, J Endocrinol. 161(1), 167-175.
35. ten Bokum, A. M., Hofland, L. J. and Hagen, P. M.van: 2000, Eur. Cytokine Netw. 11(2), 161-176.
36. Tompa, A., Jakab, M. G., Major, J., Idei, M., Bocsi, J., Mihalik, R., Szende, B. and Keri, G.: 2000, Mutat. Res. 465(1-2), 61-68.
37. Toth, I.: 1994, J.I Drug Target. 2(3), 217-239.
38. Tóth, I., Malkinson, J. P., Flinn, N., Drouillat, B., Horváth, A., Horváth, J., Érchegyi, J., Idei, M., Venetianer, A., Artursson, P., Lazorova, L., Szende, B. and Kéri, Gy.: 1999, J. Med. Chem. 42(19), 4010-4013.
39. Tovari, J., Szende, B., Bocsi, J., Falaschi, A., Simoncsits, A., Pongor, S., Erchegyi, J., Stetak, A. and Keri, G.: 1998, Cell. Signal. 10(4), 277-282.
40. Wessel, H. P., Mitchell, C, Lobato, C. M. and Schmid, G.: 1996, Angew. Chem. 34, 2712-2713.
41. Zheng, H., Fink, D., Li, H., Jiang, X., Aebi, S., Law, P., Goodman, M. and Howell, S. B.: 1997, Clin. Cancer Res. 3(8), 1323-1330.